These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12410066)

  • 1. Paroxetine in the treatment of adolescent major depression.
    Silveira R; Jainer AK; Singh R
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1270; author reply 1271. PubMed ID: 12410066
    [No Abstract]   [Full Text] [Related]  

  • 2. Paroxetine in the treatment of adolescent major depression.
    Correll CU; Pleak RR
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1269; author reply 1270. PubMed ID: 12410065
    [No Abstract]   [Full Text] [Related]  

  • 3. Delirium associated with paroxetine in an elderly depressive patient: a case report.
    Wakeno M; Okugawa G; Takekita Y; Kato M; Fukuda T; Yamashita M; Hosoi Y; Azuma J; Kinoshita T
    Pharmacopsychiatry; 2007 Sep; 40(5):199-200. PubMed ID: 17874351
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels.
    Yoshimura R; Ikenouchi-Sugita A; Umene-Nakano W; Hori H; Ueda N; Nakamura J
    J Clin Psychopharmacol; 2010 Feb; 30(1):82-3. PubMed ID: 20075657
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin syndrome: case report and review of the literature.
    Weiner AL; Tilden FF; McKay CA
    Conn Med; 1997 Nov; 61(11):717-21. PubMed ID: 9419960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positional asphyxiation from paroxetine.
    Malik A; Ravasia S
    Am J Psychiatry; 2005 Jun; 162(6):1225-6. PubMed ID: 15930078
    [No Abstract]   [Full Text] [Related]  

  • 7. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 8. SSRI-induced enuresis: a case report.
    Monji A; Yanagimoto K; Yoshida I; Hashioka S
    J Clin Psychopharmacol; 2004 Oct; 24(5):564-5. PubMed ID: 15349022
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.
    Hébant B; Guillaume M; Desbordes M; Gaillon G; Maltête D; Lefaucheur R
    Rev Neurol (Paris); 2016 Dec; 172(12):788-789. PubMed ID: 27838092
    [No Abstract]   [Full Text] [Related]  

  • 10. Paroxetine in adolescent major depression.
    Parsons M
    J Am Acad Child Adolesc Psychiatry; 2002 Apr; 41(4):364; author reply 364. PubMed ID: 11931589
    [No Abstract]   [Full Text] [Related]  

  • 11. Restoring Study 329: Paroxetine neither effective nor safe for adolescents.
    Mulder R; Rucklidge JJ; Toop L
    Aust N Z J Psychiatry; 2016 Sep; 50(9):922-3. PubMed ID: 27389067
    [No Abstract]   [Full Text] [Related]  

  • 12. Paroxetine in adolescent major depression.
    Weintrob A
    J Am Acad Child Adolesc Psychiatry; 2002 Apr; 41(4):363-4; author reply 364. PubMed ID: 11931587
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.
    Elliott AJ; Uldall KK; Bergam K; Russo J; Claypoole K; Roy-Byrne PP
    Am J Psychiatry; 1998 Mar; 155(3):367-72. PubMed ID: 9501747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
    Keller MB; Ryan ND; Strober M; Klein RG; Kutcher SP; Birmaher B; Hagino OR; Koplewicz H; Carlson GA; Clarke GN; Emslie GJ; Feinberg D; Geller B; Kusumakar V; Papatheodorou G; Sack WH; Sweeney M; Wagner KD; Weller EB; Winters NC; Oakes R; McCafferty JP
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):762-72. PubMed ID: 11437014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.
    Reis M; Aberg-Wistedt A; Agren H; Höglund P; Akerblad AC; Bengtsson F
    Hum Psychopharmacol; 2004 Jul; 19(5):283-91. PubMed ID: 15252820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine.
    Chiu HJ; Hong CJ; Chan CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):418-23. PubMed ID: 8803304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of child and adolescent depression: a matter of concern?
    Thomsen PH
    Acta Psychiatr Scand; 2007 Mar; 115(3):169-70. PubMed ID: 17302616
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.
    Lotrich FE; Pollock BG; Kirshner M; Ferrell RF; Reynolds Iii CF
    J Psychiatry Neurosci; 2008 Mar; 33(2):123-30. PubMed ID: 18330458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations.
    Yoshimura R; Umene-Nakano W; Ueda N; Ikenouchi-Sugita A; Hori H; Katsuki A; Hayashi K; Miyamoto K; Kodama Y; Nakamura J
    Hum Psychopharmacol; 2010 Aug; 25(6):487-90. PubMed ID: 20725911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.